The product contains a patented dual-ingredient formulation that combines the leading prescription acid-reducing medication omeprazole, a proton pump inhibitor, with sodium bicarbonate.
该产品包含一种获得专利的二元混剂，将一线抗酸处方药奥美拉唑(一种质子泵抑制剂)和碳酸氢钠结合。
Health care professionals and consumers should weigh the known benefits against the potential risks of proton pump inhibitors when determining if these medications are appropriate for treatment.
当决定质子泵抑制剂用于治疗时，卫生保健专业人员和消费者应权衡这些药物的利弊。
The invention relates to novel dosage forms for proton pump antagonists.
本发明涉及用于质子泵拮抗剂的新剂型。
Esomeprazole, a new proton pump inhibitor, is the S - isomer of omeprazole.
艾司奥美拉唑是一种新型的质子泵抑制剂， 它是奥美拉唑的S-型光学异构体。
This proton pump inhibitor was already approved for adolescents between the ages of 12 to 17.
这种质子泵抑制剂已经被批准用于12岁至17岁的青少年。
Rabeprazole exerts its action much more quickly than the other proton pump inhibitors previously developed.
雷贝拉唑比前期上市的其他质子泵抑制剂可以更快速的发挥作用。
The invention relates to alkaline salts of proton pump inhibitors and to medicaments comprising these compounds.
本发明涉及质子泵抑制剂的碱性盐和包含这些化合物的药物。
Objective to observe the influence of proton pump inhibitor (PPI) esomeprazole on antiplatelet effect of clopidogrel.
目的观察质子泵抑制剂埃索美拉唑是否影响氯吡格雷的抗血小板聚集作用。
Esomeprazole is a new member of proton pump inhibitors (PPI) with strong suppressive effects on gastric acid secretion.
埃索美拉唑是新一代质子泵抑制剂成员，有较强的抑制胃酸分泌效应。
Objective to clarify whether proton pump inhibitors (PPIs) stimulate Cyclooxygenase-2 (COX-2) expression in rat gastric mucosa.
目的探讨质子泵抑制剂(PPI)对大鼠胃粘膜环氧化酶—2 (COX - 2)表达的影响。
The present preparation comprises a fixed oral dosage form comprising a proton pump inhibitor in combination with acetyl salicylic acid.
该制剂包括含有质子泵抑制剂与乙酰水杨酸组合的固定的口服剂型。
The invention relates to the combination of reversible proton pump inhibitors and airway therapeutics for the treatment of airway disorders.
本发明涉及用于治疗气道病症的可逆的质子泵抑制剂和气道治疗剂的组合。
Lansoprazole (LPZ) that has been widely used for the treatment of acid-related diseases is a relatively novel class of proton pump inhibitors (PPIs).
兰索拉唑(LPZ)是近年来开发并已被广泛用于治疗胃酸相关性疾病的新型质子泵抑制剂。
Both the Warnings and Precautions section of the prescription labeling and the Drug Facts label on OTC proton pump inhibitors will address these findings.
处方的警告和注意事项，非处方质子泵抑制剂的药品事实说明书将对这些结果进行说明。
Conclusion: H_2 receptor antagonists induce the desensitization of the H2 receptor on the the rat gastric parietal cell, but proton pump inhibitors do not have tolerance.
结论H 2受体拮抗剂能够诱导壁细胞H 2受体出现脱敏，质子泵抑制剂未出现耐受现象。
Earlier reports have linked proton pump inhibitors to other complications, including community-acquired pneumonia, hip fractures and diarrhea associated with Clostridium difficile.
早期有报道称质子泵抑制剂可引起其它并发症，如社区获得性肺炎，髋骨折，艰难梭菌相关性腹泻。
Prescription proton pump inhibitors are used to treat conditions such as gastroesophageal reflux disease (GERD), stomach and small intestine ulcers, and inflammation of the esophagus.
处方质子泵抑制剂用于治疗的疾病如反流性胃食管疾病(GERD)、胃和小肠溃疡、食道炎症。
The present invention belongs to the field of medicine preparation, in the concrete, it relates to a composition of substituted benzimidazole proton pump inhibitor and its preparation method.
本发明涉及药物制剂领域，具体涉及含取代苯并咪唑质子泵抑制剂的组合物及其制备方法。
Since the first proton pump inhibitor (Omeprazole) came into the market in 1988, PPIs have been considered as the drugs of first choice for treatment of patients with various acid-related diseases.
自第一个质子泵抑制剂(PPI)奥美拉唑于1988年上市以来，PPI已成为酸相关性疾病治疗的首选药物。
Proton pump inhibitors can tackle really stubborn heartburn.
质子泵抑制剂可以治疗顽固性胃灼热。
Proton Pump Inhibitor and Clopidogrel Interaction: Fact or Fiction?
质子泵抑制剂和氯吡格雷的相互作用：是真是假？
Proton pump inhibitor (PPI) is considered as the standard treatment for acid-related disorders.
质子泵抑制剂的应用是酸相关疾病的标准治疗。
Proton pump inhibit test showed that positive ratio was 81% in the patients who showed effective after treatment.
质子泵抑制试验表明，治疗有效或显著有效的病人中81%试验阳性。
Rabeprazole is a new type of Proton Pump Inhibitors, which is widely used in therapy for digestive system illness.
雷贝拉唑是一种新型的质子泵抑制剂，广泛应用于消化系统疾病的治疗。
Proton pump inhibitors, available by prescription and over-the-counter (OTC), work by reducing the amount of acid in the stomach.
质子泵抑制剂，可以处方和非处方取药，主要通过减少胃酸量而发挥作用。
OBJECTIVE: To make a comprehensive comment on rational use of proton-pump inhibitors.
目的：为质子泵抑制剂的合理应用作一全面的评述。
One is levofloxacin triple therapy, which consists of a PPI (proton-pump inhibitor) along with amoxicillin and levofloxacin.
一个是左氧氟沙星三联疗法，将PPI和阿莫西林及左氧氟沙星结合使用。
One is levofloxacin triple therapy, which consists of a PPI (proton-pump inhibitor) along with amoxicillin and levofloxacin.
一个是左氧氟沙星三联疗法，将PPI和阿莫西林及左氧氟沙星结合使用。
应用推荐